|Bid||1.5400 x 34100|
|Ask||0.0000 x 4000|
|Day's Range||1.6100 - 1.6900|
|52 Week Range||1.1300 - 4.3800|
|Beta (5Y Monthly)||-1.75|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.40|
Athersys, Inc. (Nasdaq: ATHX) will release its third quarter 2020 financial results on Monday, November 9, 2020.
Investors need to pay close attention to Athersys (ATHX) stock based on the movements in the options market lately.
The FDA bestows a Regenerative Medicine Advanced Therapy status on Athersys' (ATHX) MultiStem cell therapy candidate for treating acute respiratory distress syndrome.